The American Conference Institute hosted the 12th Annual Forum on Biotech Patents, which featured preeminent biotech practitioners who provided insight and effective guidance on the biotech patent industry, and discussed case law and landmark legislation.
WilmerHale Partner Emily Whelan was a featured speaker at this event. She spoke on the topic, "35 U.S.C. §271(e)(1) Safe Harbor Protection In Drug Development."